DC
SCMP

Deere & Company’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Deere & Company’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-27,845
Closed -$481K – 1297
2015
Q4 		$481K Buy
27,845
+578
+2% +$10.4K 0.03% 571
2015
Q3 		$542K Sell
27,267
-43,208
-61% -$991K 0.03% 504
2015
Q2 		$1.16M Buy
+70,475
New +$1.22M 0.06% 310
2014
Q2 		– Sell
-18,352
Closed -$131K – 1072
2014
Q1 		$131K Sell
18,352
-3,472
-16% -$29.7K 0.01% 896
2013
Q4 		$205K Hold
21,824
– – 0.01% 920
2013
Q3 		$136K Hold
21,824
– – 0.01% 957
2013
Q2 		$144K Buy
+21,824
New +$173K 0.01% 924

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Deere & Company's SCMP Position: Q1 2016 in Review

Deere & Company sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2016, closing a stake of 27,845 shares — an estimated $481K sold.

Deere & Company first reported a position in SCMP in Q2 2013 and held it in 7 quarters. The position peaked at $1.16M in Q2 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

  • Deere & Company reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 27,845 Sucampo Pharmaceuticals, Inc. shares in Q1 2016, an estimated $481K.
  • Deere & Company first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
  • Deere & Company's Sucampo Pharmaceuticals, Inc. position peaked at $1.16M in Q2 2015.
  • 134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.